OCT for Retinas

Carl Zeiss AG, Camera LensesRequest Info
Facebook X LinkedIn Email
Carl Zeiss AG has announced AngioPlex optical coherence tomography (OCT) imaging technology for the diagnosis of retinal diseases.

The technology uses amplitude and phase aspects of the OCT signal, and novel algorithms to enable highly detailed visualizations of the retinal microvasculature. It detects capillary flow rather than the presence of injected dye, and can discriminate capillaries at the superficial and deep retina while generating a color map of the retinal vessels, providing a view of diseased capillaries and net structures.

Pathologies amenable to this examination include diabetic retinopathy, vein occlusions, age-related macular degeneration and pathological myopia.

Published: February 2016
* First Name:
* Last Name:
* Email Address:
* Company:
* Country:

When you click "Send Request", we will record and send your personal contact information to Carl Zeiss AG, Camera Lenses by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.

Register or login to auto-populate this form:
Login Register
* Required

ProductsAngioPlexCarl Zeissretinal diseaseZeissEuropeBiophotonicsImagingGermanyOCT

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.